Protagenic Therapeutics (PTIX) said Tuesday that it has struck a deal to sell about 1.95 million shares, series A warrants and series B warrants to raise about $1.275 million for working capital.
The purchase price of each share and associated warrants will be $0.64, the firm said. It expects to close the offering Nov 4, with Brookline Capital Markets, a division of Arcadia Securities, as the placement agent.
The stock was down more than 10% in recent trading.
Price: 0.57, Change: -0.07, Percent Change: -10.49
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。